Mylab & Serum Institute of India launched Nasovac S4 last week. It's being seen as major step towards increasing acceptance of flu vaccines in India, where uptake has been low.
The fever, which doctors describe as more severe than is usual in this season, mostly affecting children & adults with comorbidities. No life-threatening case so far, doctors say.
No. of H3N2 cases has doubled since last spike in 2021. Experts say low popularity of flu vaccines, comorbidities & allergens in air can be why people are becoming more susceptible to it.
In tactical terms, the shirtless protest was worse than a self-goal. Suddenly, the fiascos of the AI Summit were forgotten, and the Youth Congress’s disruption became the issue.
IAF is fine with accepting the aircraft with 'must-haves', even if some other steps remain pending, which may take at least another year, it is learnt.
COMMENTS